These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 11405532

  • 21. Recent developments in the use of biologics targeting IL-5, IL-4, or IL-13 in severe refractory asthma.
    Walsh GM.
    Expert Rev Respir Med; 2018 Nov; 12(11):957-963. PubMed ID: 30193532
    [Abstract] [Full Text] [Related]

  • 22. An update on biologic-based therapy in asthma.
    Walsh GM.
    Immunotherapy; 2013 Nov; 5(11):1255-64. PubMed ID: 24188679
    [Abstract] [Full Text] [Related]

  • 23. Antiallergic asthma properties of brazilin through inhibition of TH2 responses in T cells and in a murine model of asthma.
    Lee CC, Wang CN, Kang JJ, Liao JW, Chiang BL, Chen HC, Hu CM, Lin CD, Huang SH, Lai YT.
    J Agric Food Chem; 2012 Sep 19; 60(37):9405-14. PubMed ID: 22920671
    [Abstract] [Full Text] [Related]

  • 24. Biological treatments for severe asthma: A major advance in asthma care.
    Busse WW.
    Allergol Int; 2019 Apr 19; 68(2):158-166. PubMed ID: 30792118
    [Abstract] [Full Text] [Related]

  • 25. An update on emerging drugs for asthma.
    Walsh GM.
    Expert Opin Emerg Drugs; 2012 Mar 19; 17(1):37-42. PubMed ID: 22292562
    [Abstract] [Full Text] [Related]

  • 26. Eosinophil apoptosis as a therapeutic target in allergic asthma.
    Ilmarinen P, Kankaanranta H.
    Basic Clin Pharmacol Toxicol; 2014 Jan 19; 114(1):109-17. PubMed ID: 24148899
    [Abstract] [Full Text] [Related]

  • 27. Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma.
    Peters MC, Wenzel SE.
    Lancet; 2020 Feb 01; 395(10221):371-383. PubMed ID: 32007172
    [Abstract] [Full Text] [Related]

  • 28. Protective Role of Eosinophils and TNFa after Ozone Inhalation.
    Fryer AD, Jacoby DB, Wicher SA.
    Res Rep Health Eff Inst; 2017 Mar 01; 2017(191):1-41. PubMed ID: 29659241
    [Abstract] [Full Text] [Related]

  • 29. Emerging interleukin receptor antagonists for the treatment of asthma.
    Al Efraij K, FitzGerald JM.
    Expert Opin Emerg Drugs; 2017 Sep 01; 22(3):275-283. PubMed ID: 28832218
    [Abstract] [Full Text] [Related]

  • 30. Anti-interleukin-5 therapy in severe asthma.
    Garcia G, Taillé C, Laveneziana P, Bourdin A, Chanez P, Humbert M.
    Eur Respir Rev; 2013 Sep 01; 22(129):251-7. PubMed ID: 23997052
    [Abstract] [Full Text] [Related]

  • 31. YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models.
    Yoshino T, Ishikawa J, Ohga K, Morokata T, Takezawa R, Morio H, Okada Y, Honda K, Yamada T.
    Eur J Pharmacol; 2007 Apr 10; 560(2-3):225-33. PubMed ID: 17307161
    [Abstract] [Full Text] [Related]

  • 32. 18β-Glycyrrhetinic acid, the major bioactive component of Glycyrrhizae Radix, attenuates airway inflammation by modulating Th2 cytokines, GATA-3, STAT6, and Foxp3 transcription factors in an asthmatic mouse model.
    Kim SH, Hong JH, Lee JE, Lee YC.
    Environ Toxicol Pharmacol; 2017 Jun 10; 52():99-113. PubMed ID: 28410469
    [Abstract] [Full Text] [Related]

  • 33. Anti-IL-4/-13 based therapy in asthma.
    Walsh GM.
    Expert Opin Emerg Drugs; 2015 Sep 10; 20(3):349-52. PubMed ID: 26021492
    [Abstract] [Full Text] [Related]

  • 34. Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model.
    Lee MY, Seo CS, Lee NH, Ha H, Lee JA, Lee H, Lee KY, Shin HK.
    Int Immunopharmacol; 2010 Nov 10; 10(11):1374-9. PubMed ID: 20727999
    [Abstract] [Full Text] [Related]

  • 35. [Asthma: prevalence, pathogenesis and perspectives on new treatments].
    Carrada Bravo T.
    Rev Alerg Mex; 2002 Nov 10; 49(3):87-94. PubMed ID: 12190004
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetic/pharmacodynamic drug evaluation of benralizumab for the treatment of asthma.
    Matera MG, Calzetta L, Rinaldi B, Cazzola M.
    Expert Opin Drug Metab Toxicol; 2017 Sep 10; 13(9):1007-1013. PubMed ID: 28737051
    [Abstract] [Full Text] [Related]

  • 37. The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation.
    Asquith KL, Ramshaw HS, Hansbro PM, Beagley KW, Lopez AF, Foster PS.
    J Immunol; 2008 Jan 15; 180(2):1199-206. PubMed ID: 18178860
    [Abstract] [Full Text] [Related]

  • 38. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.
    Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M.
    J Exp Med; 1995 Nov 01; 182(5):1527-36. PubMed ID: 7595222
    [Abstract] [Full Text] [Related]

  • 39. A new compound, 1H,8H-pyrano[3,4-c]pyran-1,8-dione, suppresses airway epithelial cell inflammatory responses in a murine model of asthma.
    Lee H, Han AR, Kim Y, Choi SH, Ko E, Lee NY, Jeong JH, Kim SH, Bae H.
    Int J Immunopathol Pharmacol; 2009 Nov 01; 22(3):591-603. PubMed ID: 19822076
    [Abstract] [Full Text] [Related]

  • 40. Eosinophils and eosinophil-associated cytokines in allergic inflammation.
    Kay AB, Barata L, Meng Q, Durham SR, Ying S.
    Int Arch Allergy Immunol; 1997 Nov 01; 113(1-3):196-9. PubMed ID: 9130521
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.